朗科智能(300543.SZ):取消購買辦公物業
格隆匯4月17日丨朗科智能(300543.SZ)公佈,公司於2019年4月23日召開了第三屆董事會第六次會議和第三屆監事會第五次會議,審議通過了《關於購買公司辦公物業的議案》。同意公司以自籌資金的方式在深圳市寶安區市區範圍內購買辦公物業,作為公司總部的辦公場所。
因市場環境發生變化,同時綜合考慮公司未來業務發展規劃,經審慎研究,公司同意取消此購買交易。至此,雙方已按照之前協議約定辦理完畢相關取消事項,公司與交易對方即深圳市瑞恆投資發展有限公司已就上述購買事宜涉及的權利、義務全部結清,此次取消辦公物業購買事宜,不會對公司整體業務發展和盈利水平產生重大影響,也不會損害公司及股東、特別是中小股的利益。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.